#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary haemorrhagic telangiectasia Metachromatic leukodystrophy Osteosarcoma Cystic fibrosis gastrointestinal disease B-cell lymphoma refractory Marginal zone lymphoma refractory Infantile apnoea Cutaneous T-cell lymphoma refractory Retinoblastoma Myeloid leukaemia Acute leukaemia Gastrointestinal neuroendocrine tumour Neurofibromatosis Leber's congenital amaurosis Adenovirus infection More trials…

    Learn about Rare Diseases

    Indolent systemic mastocytosis – Trials in Disease Pituitary-dependent Cushing’s syndrome – Diagnostics Loeys-Dietz syndrome – Diagnostics Epidermolysis bullosa – Trials in Disease Mantle cell lymphoma – Basic Information Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Basic Information Marfan’s syndrome – Diagnostics Sarcoma – Trials in Disease Primary hyperoxaluria – Diagnostics Focal segmental glomerulosclerosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Promethazine Hydrochloride Azenosertib Felzartamab Carisbamate Opevesostat Iron Yttrium-90 VERTEPORFIN Naproxen Pegaspargase Pervi-Neo Rbd5044 Sodium Hydrocortisone Hemisuccinate SUMATRIPTAN Ngm707 Tralokinumab Phenobarbital Ads-015 177Lu-Rhpsma-10.1 Sabatolimab More therapies…

    Learn about Your Condition

    Metachromatic leukodystrophy Small for dates baby Frostbite Neuropathy peripheral Andersen-Tawil syndrome Endometrial cancer stage IV Myelofibrosis Retinitis pigmentosa Infantile spasms Primary hyperoxaluria Ovarian cancer recurrent Injury Medication overuse headache Complicated appendicitis Peripheral ischaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Evaluation of Cefazolin versus Placebo for Preventing Surgical Site Infection in Breast Cancer Lumpectomy Patients

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Cefazolin Sodium
    • Sodium Chloride Ph. Eur.
    • Sodium Hydrogen Carbonate Pheur
    France

  • Phase 2 Study of RADAMTS13 in Adults with Acute Ischemic Stroke

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Belgium France Germany Greece

  • Phase II Study of Cemiplimab to Spare Surgery in Patients with Locally Advanced Cutaneous Squamous Cell Carcinoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of skin
    Investigated Drugs:
    • Cemiplimab
    Italy

  • Safety and Tolerability of Lutetium‑177 Vipivotide Tetraxetan Combined with Gozetotide in Women with Metastatic Triple‑Negative Breast Cancer

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Gozetotide
    • Lutetium (177Lu) Vipivotide Tetraxetan
    Germany

  • Efficacy and Safety of Pegcetacoplan in Adults and Adolescents with Focal Segmental Glomerulosclerosis: Phase 2/3 Open‑Label and Randomized Placebo‑Controlled Study

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Focal segmental glomerulosclerosis
    Investigated Drugs:
    • Pegcetacoplan
    France Germany Italy Poland Portugal Slovakia +1

  • Model‑informed precision dosing of linezolid in ICU patients with bacterial pneumonia, skin or soft‑tissue infection: a randomized clinical trial

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Bacterial infection
    Investigated Drugs:
    • Linezolid
    Germany
Previous Page
1 … 678 679 680 681 682 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!